407 related articles for article (PubMed ID: 22857823)
1. Immune senescence and vaccines to prevent herpes zoster in older persons.
Levin MJ
Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
[TBL] [Abstract][Full Text] [Related]
2. Zoster vaccine: current status and future prospects.
Oxman MN
Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
[TBL] [Abstract][Full Text] [Related]
4. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
Levin MJ; Oxman MN; Zhang JH; Johnson GR; Stanley H; Hayward AR; Caulfield MJ; Irwin MR; Smith JG; Clair J; Chan IS; Williams H; Harbecke R; Marchese R; Straus SE; Gershon A; Weinberg A;
J Infect Dis; 2008 Mar; 197(6):825-35. PubMed ID: 18419349
[TBL] [Abstract][Full Text] [Related]
5. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
[TBL] [Abstract][Full Text] [Related]
6. Varicella zoster virus vaccines: effective, but concerns linger.
Liesegang TJ
Can J Ophthalmol; 2009 Aug; 44(4):379-84. PubMed ID: 19606157
[TBL] [Abstract][Full Text] [Related]
7. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
Berger R; Luescher D; Just M
Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
[TBL] [Abstract][Full Text] [Related]
8. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
[TBL] [Abstract][Full Text] [Related]
10. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
11. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
Schmid DS; Miao C; Leung J; Johnson M; Weinberg A; Levin MJ
J Virol; 2021 May; 95(12):. PubMed ID: 33762414
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.
Irwin MR; Levin MJ; Laudenslager ML; Olmstead R; Lucko A; Lang N; Carrillo C; Stanley HA; Caulfield MJ; Weinberg A; Chan IS; Clair J; Smith JG; Marchese RD; Williams HM; Beck DJ; McCook PT; Zhang JH; Johnson G; Oxman MN
Clin Infect Dis; 2013 Apr; 56(8):1085-93. PubMed ID: 23413415
[TBL] [Abstract][Full Text] [Related]
13. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine.
Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C
J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990
[TBL] [Abstract][Full Text] [Related]
15. Herpes zoster virus vaccine.
Woolery WA
Geriatrics; 2008 Oct; 63(10):6-9. PubMed ID: 18828650
[TBL] [Abstract][Full Text] [Related]
16. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
[TBL] [Abstract][Full Text] [Related]
17. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ
J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114
[TBL] [Abstract][Full Text] [Related]
18. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
[TBL] [Abstract][Full Text] [Related]
19. Vaccination to prevent herpes zoster in older adults.
Gnann JW
J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
[TBL] [Abstract][Full Text] [Related]
20. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK
Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]